• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Probable serine carboxypeptidase CPVL (CPVL)

The expression region of this recombinant Human CPVL covers amino acids 23-476. The calculated molecular weight for this CPVL protein is 67.9 kDa. This CPVL recombinant protein is manufactured in e.coli. The N-terminal 6xHis-SUMO tag was fused into the coding gene segment of CPVL, making it easier to detect and purify the CPVL recombinant protein in the later stages of expression and purification.The human probable serine carboxypeptidase CPVL contains a serine carboxypeptidase-like domain and is expressed in various tissues, including the liver, pancreas, and kidney. CPVL is believed to possess serine carboxypeptidase-like activity and is involved in the post-translational modification of proteins. Some research suggests its potential association with conditions such as metabolic disorders and pancreatic cancer.

ACP04082

The expression region of this recombinant Human CPVL covers amino acids 23-476. The calculated molecular weight for this CPVL protein is 67.9 kDa. This CPVL recombinant protein is manufactured in e.coli. The N-terminal 6xHis-SUMO tag was fused into the coding gene segment of CPVL, making it easier to detect and purify the CPVL recombinant protein in the later stages of expression and purification.The human probable serine carboxypeptidase CPVL contains a serine carboxypeptidase-like domain and is expressed in various tissues, including the liver, pancreas, and kidney. CPVL is believed to possess serine carboxypeptidase-like activity and is involved in the post-translational modification of proteins. Some research suggests its potential association with conditions such as metabolic disorders and pancreatic cancer.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP04082 Target NameCPVL
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range23-476aaMol Weight67.9kDa
Protein LengthFull Length of Mature ProteinPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H3G5
Background Information
  • Uniprot Id

    Q9H3G5

  • Target Species

    Human

  • Target Name

    CPVL

  • Target Full Name

    Probable serine carboxypeptidase CPVL

  • Target Function

    May be involved in the digestion of phagocytosed particles in the lysosome, participation in an inflammatory protease cascade, and trimming of peptides for antigen presentation.

  • Target Protein Families

    Peptidase S10 family

  • Target Tissue Specificity

    Expressed in macrophages but not in other leukocytes. Abundantly expressed in heart and kidney. Also expressed in spleen, leukocytes, and placenta.

  • Target Research Area

    Cell Biology

  • Target Synonyms

    Carboxypeptidase; Carboxypeptidase vitellogenic like; carboxypeptidase WUG; CP-Mac carboxypeptidase; cpvl; CPVL_HUMAN; HVLP; MGC10029; Probable serine carboxypeptidase CPVL; Serine carboxypeptidase vitellogenic like; VCP like protein; VCP-like protein; Vitellogenic carboxypeptidase like protein; Vitellogenic carboxypeptidase-like protein; vitellogenic-like; VLP

  • Target Background

    The protein encoded by this gene is a carboxypeptidase and bears strong sequence similarity to serine carboxypeptidases. Carboxypeptidases are a large class of proteases that act to cleave a single amino acid from the carboxy termini of proteins or peptides. The exact function of this protein, however, has not been determined.

Inquire Recombinant Human Probable serine carboxypeptidase CPVL (CPVL) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification